Evidence map›Paper›PMID 41766791›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2026

Development of anti-dengue virus D8 neutralizing monoclonal antibody production in

Gunt Niyompun, Kaewta Rattanapisit, Janejira Jaratsittisin, Pipob Suwanchaikasem, Rochanawan Sootichote, Pichamon Sittikul, Pannamthip Pitaksajjakul, Pongrama Ramasoota, Waranyoo Phoolcharoen

Abstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gunt NiyompunMSc. Program in Research for Enterprise, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Kaewta RattanapisitBaiya Phytopharm Co., Ltd, Bangkok 10330, Thailand.
Janejira JaratsittisinBaiya Phytopharm Co., Ltd, Bangkok 10330, Thailand.
Pipob SuwanchaikasemBaiya Phytopharm Co., Ltd, Bangkok 10330, Thailand.
Rochanawan SootichoteCenter of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
Pichamon SittikulDepartment of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
Pannamthip PitaksajjakulCenter of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
Pongrama RamasootaCenter of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
Waranyoo PhoolcharoenDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue is a life-threatening mosquito-borne viral disease ranging from mild symptoms to severe hemorrhagic fever. In this study, a recombinant anti-dengue D8 monoclonal antibody was produced in

Indexed as

D8Dengue virusMonoclonal antibodyNicotiana benthamiana

Identifiers

PMID41766791
PMCPMC12937009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.